| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PAM |
| Uniprot No | P19021 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-866aa |
| 氨基酸序列 | MAGRVPSLLVLLVFPSSCLAFRSPLSVFKRFKETTRPFSNECLGTTRPVV PIDSSDFALDIRMPGVTPKQSDTYFCMSMRIPVDEEAFVIDFKPRASMDT VHHMLLFGCNMPSSTGSYWFCDEGTCTDKANILYAWARNAPPTRLPKGVG FRVGGETGSKYFVLQVHYGDISAFRDNNKDCSGVSLHLTRLPQPLIAGMY LMMSVDTVIPAGEKVVNSDISCHYKNYPMHVFAYRVHTHHLGKVVSGYRV RNGQWTLIGRQSPQLPQAFYPVGHPVDVSFGDLLAARCVFTGEGRTEATH IGGTSSDEMCNLYIMYYMEAKHAVSFMTCTQNVAPDMFRTIPPEANIPIP VKSDMVMMHEHHKETEYKDKIPLLQQPKREEEEVLDQDFHMEEALDWPGV YLLPGQVSGVALDPKNNLVIFHRGDHVWDGNSFDSKFVYQQIGLGPIEED TILVIDPNNAAVLQSSGKNLFYLPHGLSIDKDGNYWVTDVALHQVFKLDP NNKEGPVLILGRSMQPGSDQNHFCQPTDVAVDPGTGAIYVSDGYCNSRIV QFSPSGKFITQWGEESSGSSPLPGQFTVPHSLALVPLLGQLCVADRENGR IQCFKTDTKEFVREIKHSSFGRNVFAISYIPGLLFAVNGKPHFGDQEPVQ GFVMNFSNGEIIDIFKPVRKHFDMPHDIVASEDGTVYIGDAHTNTVWKFT LTEKLEHRSVKKAGIEVQEIKEAEAVVETKMENKPTSSELQKMQEKQKLI KEPGSGVPVVLITTLLVIPVVVLLAIAIFIRWKKSRAFGDSEHKLETSSG RVLGRFRGKGSGGLNLGNFFASRKGYSRKGFDRLSTEGSDQEKEDDGSES EEEYSAPLPALAPSSS |
| 预测分子量 | 121 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于PAM(Peptidylglycine α-Amidating Monooxygenase)重组蛋白的3篇参考文献及其摘要概括：
1. **文献名称**：*Expression and Functional Characterization of Recombinant Peptidylglycine α-Amidating Monooxygenase in CHO Cells*
**作者**：Kolhekar AS, et al.
**摘要**：研究在CHO细胞中成功表达重组PAM，验证其双酶(单加氧酶和裂解酶)活性，证实其能够催化神经肽前体的C端酰胺化，为大规模生产提供了基础。
2. **文献名称**：*Purification and Kinetic Analysis of Recombinant Bifunctional PAM from Drosophila*
**作者**：Jiang N, et al.
**摘要**：通过昆虫细胞系统表达并纯化果蝇来源的双功能PAM，分析其酶动力学参数，揭示其在不同pH和金属离子条件下的催化效率差异。
3. **文献名称**：*Structural Insights into Recombinant Human PAM for Neuropeptide Therapeutics*
**作者**：Prigge ST, et al.
**摘要**：解析重组人源PAM的晶体结构，阐明其底物结合域和催化机制，为设计靶向PAM的神经退行性疾病药物提供结构基础。
(注：以上文献信息为示例，实际引用时请核实真实文献。)
**Background of PAM Recombinant Proteins**
PAM (Peptidylglycine α-Amidating Monooxygenase) recombinant proteins are engineered variants of the native enzyme critical for amidated peptide hormone biosynthesis. PAM catalyzes the two-step α-amidation of glycine-extricted propeptides, a post-translational modification essential for the bioactivity of hormones like vasopressin, oxytocin, and neuropeptides. Native PAM is a bifunctional enzyme with two catalytic domains: peptidylglycine α-hydroxylating monooxygenase (PHM) and peptidyl-α-hydroxyglycine α-amidating lyase (PAL).
Recombinant PAM proteins are generated via genetic engineering, often expressed in heterologous systems (e.g., mammalian, insect, or yeast cells) to overcome challenges in isolating the native enzyme from tissues. These systems enable scalable production, improved purity, and customization (e.g., truncated forms or domain-specific variants). PHM and PAL domains are frequently studied separately to dissect their mechanisms or optimize amidating efficiency.
Research on PAM recombinant proteins has advanced understanding of copper-dependent monooxygenase chemistry and substrate specificity. Applications span biotechnology and therapeutics, including the synthesis of amidated peptides for drug development and enzyme replacement strategies. Challenges remain in maintaining structural stability and catalytic activity in vitro, driving innovations in expression systems and protein engineering.
Overall, PAM recombinant proteins serve as vital tools in peptide engineering and endocrine research, bridging gaps between biochemical discovery and therapeutic innovation. Their study continues to reveal insights into enzyme dynamics and peptide hormone regulation, with implications for treating metabolic and neurological disorders.
×
